CB-06

N/A

Report date: 2025/05/22 20:00:09
NME

Base Information

Drug NameCB-06
Drug Alias NameCB-06CB-06036CB06-036CB06
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 8 agonists
TargetsToll like receptor 8
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Zhimeng Biopharma Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Zhimeng Biopharma IncGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsHepatitis B, ChronicHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A